cbdMD opened higher at $0.40, compared with its previous close of $0.40. In the last trading session, the stock traded between $0.39 and $0.41. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in cbdMD is now worth
$ 0.06
Resulting in a loss of
$ 99.94 (99.94%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
$-0.00 (-0.51%)
Day High
$0.41
Day Low
$0.39
Day Open
$0.40
Prev Close
$0.40
Volume
54,516
1W Return
-0.76%
1M Return
8.86%
3M Return
-31.77%
6M Return
-51.37%
1Y Return
-51.12%
Market Cap ($ Mn)
4
PE Ratio
2.17
PB Ratio
0.68
PEG Ratio
-
ROE
-57.55%
ROCE
-54.78%
EPS (TTM)
$-0.11
1 Week
-0.76%
1 Month
8.86%
3 Months
-31.77%
6 Months
-51.37%
9 Months
-47.86%
cbdMD acquires Twinlab assets for $1.75M debt and 2.23M shares
cbdMD acquires Twinlab assets via assignment for benefit of creditors. Deal consideration includes $1.75M assumed debt and 2,229,805 shares. Combined TTM revenue reaches ~$30 million, a 40% increase. Portfolio includes Reserveage, Metabolife, and Alvita Tea brands. Transaction requires court approval and customary closing conditions.
2mo agocbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11)
cbdMD Inc reported Q3FY26 net sales of $5.6 million, up 20% YoY but missing the $5.689 million estimate. EPS of $(0.11) missed the $(0.03) estimate. Wholesale sales drove growth, increasing 61% to account for 30% of total revenue. Adjusted EBITDA loss narrowed to $507,000, though gross margins declined to 54.7% due to mix shifts.
3mo agocbdMD backs Senate bill delaying federal hemp rules to Dec 11
cbdMD, Inc. supports a Senate continuing resolution delaying federal hemp restrictions until December 11. The bill protects naturally derived full-spectrum CBD but excludes synthetic cannabinoids. The measure requires further legislative action to become law, offering a temporary reprieve for the hemp industry ahead of permanent regulatory frameworks.
3mo agoBluebird Botanicals partners with Denver Audubon for conservation
cbdMD's Bluebird Botanicals brand has partnered with Denver Audubon to support bird conservation in Colorado. The "Buy Bluebird, Save Bluebirds" campaign will contribute 1% of profits from sales over three months to fund conservation and education efforts. This move aligns with cbdMD's strategy to strengthen Bluebird's brand identity following its acquisition.
4mo agocbdMD backs White House push for fair hemp product treatment
cbdMD, Inc. supports the White House's call for Congress to ensure fair treatment of hemp-derived products and revise federal regulations. The Administration's request seeks to preserve access to full-spectrum CBD while restricting harmful products, potentially extending the implementation timeline. cbdMD, listed on NYSE American, views these developments as beneficial for compliant operators and plans to leverage its position in the maturing cannabinoid market.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $1,437.29 | +0.35% | $13,52,123.38M | 39.43 | |
| $280.41 | -0.13% | $6,75,033.80M | 31.06 | |
| $294.98 | +0.37% | $5,21,411.37M | 72.17 | |
| $147.18 | -0.59% | $3,62,834.91M | 117.74 | |
| $160.32 | -1.80% | $3,26,222.34M | 23.23 | |
| $185.48 | -0.69% | $2,87,691.54M | 24.32 | |
| $468.11 | +0.62% | $2,53,205.85M | 26.86 | |
| $169.73 | -0.67% | $2,10,522.74M | - | |
| $29.45 | +0.31% | $1,67,860.70M | 36.79 | |
| $41.09 | +0.96% | $1,39,300.36M | 11.15 | |
| $62.91 | +0.18% | $1,28,593.45M | 14.67 | |
| $48.43 | +0.41% | $1,16,984.89M | 23.63 |
An investment of $100 made 5 years ago in cbdMD is now worth
$ 0.06
Resulting in a loss of
$ 99.94 (99.94%)
Note: Past profits do not guarantee future returns.
